ELAHERE is the first and only novel therapy approved in the European Union specifically for patients with folate receptor-alpha (FR?) positive, platinum-resistant ovarian cancerELAHERE represents the ...

Ovarian cancer vaccines are under development, but none are ready for primetime. There are no screening tools for ovarian ...

Ellie Wilcock, 25, first visited her GP in April 2022 after feeling abdominal pain which she initially attributed to a ...

Colorectal cancer is now the leading killer for those under 50. Two individuals have shared their experiences with Newsweek.

Drug resistance to doxorubicin is mediated through the ABCG2 protein by the TMEM158 gene.ABCG2 protein ( ATP-binding cassette sub-family G member. Is an efflux pump protein that actively transports ...

It induces a specific type of immunity, called Th17 immunity, that seems to prevent suppression of the immune system. The ...

TOP1 is the target of topotecan, which was approved in 1997 by the U.S. Food and Drug Administration (FDA) to treat relapsed ...

BATAVIA - Kristina Gilbert was taken aback at first after Genesee Cancer Assistance Executive Director Sue Underwood asked ...

In 2021, Kelli Sosa was diagnosed with ovarian cancer. While undergoing chemotherapy and surgeries, doctors determined that ...

A coalition of leading cancer organizations is joining key state lawmakers in calling for the passage of the Illinois Cancer Patients Bill of Rights, a resolution and call-to-action declaring that all ...

Nuvectis Pharma shares fell steeply after updated data from its early-stage study evaluating NXP800 to treat an aggressive type of ovarian cancer showed that a change in the dosing schedule only ...